Beckman Coulter Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Beckman Coulter Inc.
BD Sues Beckman Coulter Over Flow Cytometry Patents
Becton Dickinson claims Beckman Coulter has been knowingly violating several patents since at least 2015.
Abbott Adds IgM Test To COVID-19 Diagnostic Line-Up
The FDA has granted an emergency use authorization for a COVID-19 IgM antibody blood test that runs on Abbott’s Architect and Alinity platforms.
Beckman Coulter Addresses COVID-19 Testing From Multiple Angles
The company expects testing for IgM antibodies will be useful in areas where PCR testing is not keeping up with demand.
COVID-19 Registry Aims To Map And Address Potential Test Shortages
Medtech industry group AdvaMed has developed a registry to share data on how many COVID-19 diagnostic tests are available and where they are, with a goal of foreseeing and nipping in the bud potential test shortages. Thirteen diagnostic manufacturers – including Abbott, Roche, Siemens and Thermo Fisher Scientific – have partnered with AdvaMed on the initiative.
- Research, Analytical Equipment & Supplies
In Vitro Diagnostics
- Chemistry, Immunoassay
- Hematology, Coagulation
- Molecular Diagnostics & Genetic Testing
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.